Sandra Moore

5.6k total citations · 1 hit paper
11 papers, 1.7k citations indexed

About

Sandra Moore is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Sandra Moore has authored 11 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Genetics and 6 papers in Hematology. Recurrent topics in Sandra Moore's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Eosinophilic Disorders and Syndromes (5 papers) and Acute Myeloid Leukemia Research (3 papers). Sandra Moore is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Eosinophilic Disorders and Syndromes (5 papers) and Acute Myeloid Leukemia Research (3 papers). Sandra Moore collaborates with scholars based in United States, Switzerland and Germany. Sandra Moore's co-authors include Benjamin H. Lee, D. Gary Gilliland, Ross L. Levine, Thomas Mercher, Maricel Gozo, Elizabeth McDowell, Gerlinde Wernig, Yana Pikman, Stephanie J. Lee and Jennifer Clark and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Cancer Cell.

In The Last Decade

Sandra Moore

11 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia

2006 1.0k citations Yana Pikman, Benjamin H. Lee et al. PLoS Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Moore United States	9	1.3k	1.1k	978	445	254	11	1.7k
Rachel Okabe United States	15	1.0k 0.8×	1.0k 1.0×	1.2k 1.2×	332 0.7×	379 1.5×	22	2.0k
Hui Hao-Shen Switzerland	17	1.3k 1.0×	1.2k 1.1×	974 1.0×	464 1.0×	147 0.6×	34	1.8k
Jyoti Nangalia United Kingdom	24	1.1k 0.9×	993 0.9×	830 0.8×	399 0.9×	132 0.5×	48	1.7k
J V Melo United Kingdom	17	644 0.5×	839 0.8×	440 0.4×	390 0.9×	177 0.7×	27	1.3k
Gabriele Gugliotta Italy	20	704 0.5×	857 0.8×	246 0.3×	377 0.8×	160 0.6×	60	1.1k
Kimberly Hayes United States	19	753 0.6×	833 0.8×	428 0.4×	263 0.6×	337 1.3×	38	1.5k
Pierre Laneuville Canada	18	487 0.4×	747 0.7×	282 0.3×	229 0.5×	297 1.2×	57	1.1k
Brenton G. Mar United States	16	667 0.5×	1.5k 1.4×	982 1.0×	103 0.2×	260 1.0×	33	2.3k
Takefumi Ishii United States	15	523 0.4×	556 0.5×	390 0.4×	217 0.5×	115 0.5×	20	962
Yuri Kamitsuji Japan	16	294 0.2×	449 0.4×	369 0.4×	174 0.4×	223 0.9×	32	929

Countries citing papers authored by Sandra Moore

Since Specialization

Citations

This map shows the geographic impact of Sandra Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Moore more than expected).

Fields of papers citing papers by Sandra Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Moore. The network helps show where Sandra Moore may publish in the future.

Co-authorship network of co-authors of Sandra Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Moore. A scholar is included among the top collaborators of Sandra Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Moore. Sandra Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Buhl, Edgar, Bangfu Zhu, Mary Gainsborough, et al.. (2022). Hereditary spastic paraparesis presenting as cerebral palsy due to ADD3 variant with mechanistic insight provided by a Drosophila γ‐adducin model. Clinical Genetics. 102(6). 494–502. 4 indexed citations

2.

Joyce, Sarah, Kristiana Gordon, Glen Brice, et al.. (2015). The lymphatic phenotype in Noonan and Cardiofaciocutaneous syndrome. European Journal of Human Genetics. 24(5). 690–696. 54 indexed citations

3.

Wichmann, Christian, Yvonne Becker, Linping Chen-Wichmann, et al.. (2010). Dimer-tetramer transition controls RUNX1/ETO leukemogenic activity. Blood. 116(4). 603–613. 31 indexed citations

4.

Mercher, Thomas, Glen Raffel, Sandra Moore, et al.. (2009). The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model. Journal of Clinical Investigation. 119(4). 852–64. 73 indexed citations

5.

Cornejo, Melanie, Michael G. Kharas, Miriam B. F. Werneck, et al.. (2009). Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models. Blood. 113(12). 2746–2754. 60 indexed citations

6.

Wernig, Gerlinde, Michael G. Kharas, Rachel Okabe, et al.. (2008). Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera. Cancer Cell. 13(4). 311–320. 305 indexed citations

7.

Mercher, Thomas, Melanie Cornejo, Christopher Sears, et al.. (2008). Notch Signaling Specifies Megakaryocyte Development from Hematopoietic Stem Cells. Cell stem cell. 3(3). 314–326. 101 indexed citations

8.

Wernig, Gerlinde, Michael G. Kharas, Rachel Okabe, et al.. (2007). Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera.. Blood. 110(11). 556–556. 10 indexed citations

9.

Pikman, Yana, Benjamin H. Lee, Thomas Mercher, et al.. (2006). MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia. PLoS Medicine. 3(7). e270–e270. 1024 indexed citations breakdown →

10.

Chen, Jing, Benjamin H. Lee, Ifor R. Williams, et al.. (2005). FGFR3 as a therapeutic target of the small molecule inhibitor PKC412 in hematopoietic malignancies. Oncogene. 24(56). 8259–8267. 72 indexed citations

11.

Chen, Jing, Benjamin H. Lee, Ifor R. Williams, et al.. (2004). PKC412 Effectively Inhibits Constitutively Activated FGFR3 Mutants in Murine Leukemia Models and t(4;14) Myeloma Cell Lines.. Blood. 104(11). 2448–2448. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact